Login / Signup

A single blood eosinophil count measurement is as good as two for prediction of ICS treatment response in the IMPACT trial.

Mona BafadhelNeil BarnesStephen C BourkeChris ComptonGerard J CrinerMark T DransfieldDavid M G HalpinMeiLan K HanBenjamin HartleyC Elaine JonesPeter LangeSally LettisDavid A LipsonDavid A LomasNeil MartinFernando J MartinezRobert A WiseDave Singh
Published in: The European respiratory journal (2021)
Keyphrases
  • phase iii
  • study protocol
  • phase ii
  • clinical trial
  • peripheral blood
  • randomized controlled trial
  • placebo controlled